Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The annual conference of the International Society of Biofabrication ISBF is being held this September 17-20 in Saskatoon, Saskatchewan...

Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Cell therapy is increasingly used to treat various diseases such myocardial infarction. This therapeutic approach is limited however by the poor retention and diminished survival of transplanted cells in the ischemic, inflammatory and oxidative infarct microenvironment...

Significant bone loss due to internal or external factors remains a large orthopedic challenge. Current interventions use either autograft or allograft sources that carry a significant complication burden and show limited functional recovery, emphasizing the demand for an alternative therapeutic solution...

Encapsulation of cells within semi-permeable polymer hydrogels is a promising approach for the treatment of hormone or enzyme-deficiency disorders...

Adverse local tissue reactions to hip implants ALTRs are characterized by chronic inflammation, fibrosis and necrosis of the joints soft tissues, generating pain, swelling, increasing the risk of dislocation and failure of the reconstructive surgeries, thus reducing mobility with the subsequent detriment on the quality of life of patients 1 ...

Squamous cancer of the head and neck HNSCC is the 6th leading cancer by incidence worldwide and is known for commonly metastasizing to the lymphatic system and the bony structures in the head and neck regions...